Introduction
Bile acids (BA), commonly considered as trophic factors for the enteric epithelium, and as detergents for the emulsification and absorption of dietary lipids and fat-soluble vitamins, participate also in colon cancer progression. High fat diet and cholesterol are important risk factors for the emergence of colorectal cancers, presumably because of their associated impact on the synthesis and secretion of BA (Hill et al., 1971; Reddy, 1981; Willett et al., 1990; Nagengast et al., 1995) . Several epidemiologic studies have implicated the alterations of the production and composition of BA in the intestinal lumen and blood with the increased incidence of colorectal adenomas and adenocarcinomas (McMichael and Potter, 1985; Bayerdo¨rffer et al., 1993; Owen, 1997; Kamano et al., 1999) . Compelling evidence for a causal link between BA and colon cancer was supported by experimental carcinogenesis in rats. Cholic acid (CA), lithocholic acid (LCA), taurochenodeoxycholic acid (TCDCA) and chenodeoxycholic acid (CDCA) were considered as tumor promoters because they did not induce tumors on their own, but increased the incidence of benign adenomas and malignant adenocarcinomas when administered after a carcinogen (Narisawa et al., 1974; Reddy et al., 1977) .
Colorectal carcinogenesis is characterized by multiple molecular alterations and cellular dysfunctions, including the loss of control of growth and differentiation, and by the acquisition of undesirable cellular activities during the adenoma-adenocarcinoma transition, including cellular invasion, ectopic survival, neo-angiogenesis, and production of distant metastases. Invasion and metastasis, the hallmarks of malignant tumors, are both greatly influenced by autocrine, paracrine and endocrine factors in the tumor (Mareel et al., 1996) . Accordingly, invasion of colorectal cancer cells into collagen type I is induced by endogenous factors, such as hepatocyte growth factor (HGF), leptin and trefoil peptides (Empereur et al., 1997; Kotelevets et al., 1998; Attoub et al., 2000; Emami et al., 2001) . The possible implication of BA in cancer cell invasion is suggested by the correlation between Dukes' stage of human colon tumors, and abnormal fecal deoxycholic acid (DCA)/ cholic acid (CA) and LCA/DCA concentration ratios, as well as the number of the BA binding sites in tumor cells (Summerton et al., 1983; Owen, 1997; Kamano et al., 1999) . Recently, LCA and other BA were reported to be involved in the induction of cyclooxygenase-2 (COX-2), the secretion of matrix metalloproteinase 2 (MMP-2), and the migration of colorectal cancer cells (Halvorsen et al., 2000; Glinghammer and Rafter, 2001) .
BA are ligands of the farnesoid X (FXR) and pregnane X (PXR) nuclear receptors (Makishima et al., 1999; Parks et al., 1999; Wang et al., 1999; Staudinger et al., 2001; Xie et al., 2001) . In hepatocytes, expression of the cholesterol 7a-hydroxylase (CYP7A1) gene is regulated through the coordinated activation of the FXR and the JNK/c-Jun signaling pathways (Gupta et al., 2001) . In colorectal cancer cells, DCA and other BA, induce the activation of the activator protein-1 (AP-1) transcription factor, via a signaling cascade using protein kinase C (PKC) and the mitogenactivated p42/p44 and p38 protein kinases (MAPK) (Hirano et al., 1996; Qiao et al., 2000 Qiao et al., , 2001 . The AP-1 complex induced by DCA is composed of heterodimers including JunD, Fra-1 and c-Fos, which are actually considered as oncogenic transcription factors implicated in cellular invasion (Hennigan et al., 1994; Kustikova et al., 1998; Ozanne et al., 2000) . One of the critical target genes of AP-1 is the cyclooxygenase-2 (COX-2) gene, whose promoter activity and transcription are induced by BA in human colorectal and esophageal adenocarcinoma cells (Zhang et al., 1998; Glinghammer and Rafter, 2001 ). Induction and constitutive overexpression of COX-2 is strongly implicated in the emergence of human colorectal polyps and in cancer progression, through promotion of cell survival, invasion, and tumor angiogenesis (Fujita et al., 1998; Dannenberg and Zakim, 1999) . The proinvasive potential of the COX-2 pathway is directly connected with activation of the MMP-2 (Tsujii et al., 1997) , and the Gaq cascade using the phospholipase C and PKC signaling elements (Rodrigues et al., 2001) .
Here, we report that BA stimulate invasion of collagen type I gels by human colorectal cancer cells through haptotaxis towards selected matrix components. Furthermore, we demonstrate that these cellular activities are dependent upon several signaling pathways directly implicated in colon cancer progression, namely, the RhoA and Rac1 small GTPases, PI3-K, PKC, MAPK and COX-2.
Results
Cooperation between BA and the oncogenes SRC and RHOA in cellular invasion by premalignant colorectal and kidney epithelial cells
We first investigated whether premalignant colon and kidney epithelial cells could be stimulated to invade collagen type I gels in response to BA at the physiologic concentration of 10 mM. As shown in Figure 1 , the BA CDCA, LCA, and UDCA did not stimulate cellular invasion by premalignant human colorectal adenoma PC/AA/C1 cells. Similar negative results were obtained with CDCA, LCA and UDCA in the nontumorigenic kidney epithelial MDCKT23 cell line ( Figure 1 ). Next, we examined the possible cooperation between BA and SRC in the acquisition of the invasive phenotype using PCmsrc cells which were obtained after transfection of PC/AA/C1 cells by an expression vector encoding the activated form of the SRC oncogene (Empereur et al., 1997) . As shown in Figure 1 , CDCA and LCA, but not UDCA, stimulated the invasiveness of PCmsrc cells in collagen type I gels. Furthermore, we found that MDCKT23-RhoAV14 cells expressing a constitutively activated mutant form of the gene encoding the RhoA small GTPase (RHOA; Jou and Nelson, 1998) were also stimulated to invade collagen type I gels in response to CDCA and LCA, but not to UDCA (Figure 1) . As a control, we found that MDCKT23-RhoAN19 cells, which express a BA dose-dependently stimulate cellular invasion in human malignant PCmsrc and HCT-8/E11 cells As a next step, we determined the effects of LCA, CDCA, and UDCA on human colorectal cancer HCT-8/E11 cells. As shown in Figure 2 , cellular invasion was stimulated, by LCA and CDCA in PCmsrc and HCT-8/E11 cells, following similar dose-response curves. As described above for PCmsrc cells, UDCA was also ineffective in HCT-8/E11 cells. Maximal stimulation of invasion by BA occurred at 10 mmol/l, without apparent cytotoxicity (Figure 2 ). Higher concentrations of LCA and CDCA (100 mmol/l) were toxic, as evidenced by trypan blue staining of about 20 -30% of the whole cell population. The potency of LCA and CDCA in stimulating cellular invasion was similar in both cell types.
We compared the ability of the other non-conjugated BA CA and DCA, as well as the glyco-and tauroconjugated forms of CDCA and LCA to stimulate invasion in PCmsrc and HCT-8/E11 cells (Figure 3) . We found that both CA and DCA could stimulate this cellular activity. In contrast, the glyco-and tauroconjugated forms of CDCA (GCDCA and TCDCA), as well as the conjugated forms of LCA (GLCA and TLCA) were not competent in the two cellular models presented in Figure 3 .
The hydrophilic bile acid UDCA was previously shown to protect hepatocytes against toxicity caused by less polar BA, such as CDCA, CA and DCA (Kurtz, 1992) . Combinations of BA with UDCA were, therefore, tested in our assay. Stimulation of invasion by HCT-8/E11 and PCmsrc cells by CDCA or LCA was not altered by simultaneous addition of equimolar (10 mmol/l) concentrations of UDCA (data not shown).
Stimulation of invasion by BA and cell signaling
Because BA stimulate invasion in the transformed MDCKT23-RhoAV14 and in the tumoral PCmsrc and HCT-8/E11 cells, we tested the importance of the Rholike GTPases for this effect. We first investigated the direct effect of DCA on the activation status of RhoA and Rac1 in HCT-8/E11 colon cancer cells. Activation of these two GTPases by lysophosphatidic acid (LPA, 2.5 mmol/l) was included as a control . As shown in Figure 4a , 10 -500 mmol/l DCA increased the GTP-bound state of RhoA up to about 18-fold, at concentrations that are efficient in stimulating cell invasion, without alteration of cell viability (data not shown). In accordance with our data, Latta et al. (1993) also reported that 300 mmol/l DCA was not cytotoxic in several colorectal cancer cell lines. Thus, at concentration as low as 10 mmol/l, DCA increased the GTP-bound state of RhoA 11-fold, as observed with LPA, without any change in the total amount of this GTPase. Similarly, both LPA and 50 mmol/l DCA increased the GTP-bound state of the Rac1 GTPase up to about 30-fold, as illustrated in Figure 4b .
We next investigated the relationship between the potential of BA to stimulate invasion and the expression of the nuclear bile acid receptor FXR in the human colon PC/AA/C1, PCmsrc and HCT-8/E11 cells. As shown in Figure 5 , the BA-sensitive PCmsrc and HCT-8/E11 cell lines, but not the BA-insensitive PC/AA/C1 cell line, expressed the FXR (Figure 5 ), suggesting a possible role for the FXR in the stimulation of invasion by BA.
The aE-catenin-negative derivative HCT-8/E11R1 was not sensitive to stimulation by CDCA or LCA in the collagen type I invasion assay ( Figure 6 ). This suggests that a functional E-cadherin/catenin complex is needed for LCA-induced invasion. Accordingly, we could inhibit LCA-stimulated invasion of HCT-8/E11 cells, down to 31+9% of the control (LCA without antibody, arbitrary 100%) activity, and of PCmsrc cells, down to 61+13% of the control activity, by addition of an antibody that neutralizes the function of E-cadherin (MB2).
In complementary experiments, we have examined the functional role of the b1 and aV integrins in LCAstimulated invasion of human colon cancer cells. The addition of the neutralizing antibody P4C10 directed against the b1 integrin subunit inhibited LCAstimulated invasion of HCT-8/E11 and PCmsrc cells down to 11+8% and 20+8% of the control activity, respectively. In comparison, the 69.6.5 antibody raised against the aV integrin subunit was less efficient against LCA-stimulated invasion in HCT-8 and PCmsrc cells (inhibition down to 95+22% and 57+15% of the control activity, respectively). Next, we investigated the possible contribution of several oncogenic pathways directly implicated in tumor cell motility and invasion, namely the Rho/ Rho kinase (ROCK), PI3K, PKC, MAPK, and COX-2 signaling cascades on LCA-induced invasion. As shown in Figure 7 , pharmacological inhibitors of these signaling components reduced LCA-stimulated invasion down to 4 -55% of the control (LCA without inhibitor) activity in PCmsrc and HCT-8/E11 cells. Finally, inhibition of matrix metalloproteinases by the GM6001 compound also reduced LCA-stimulated invasion down to 39+18 and 17+14% of the control activity in HCT-8/E11 and PCmsrc cells respectively.
LCA-induced changes in morphology and motile phenotype
As a first approach to identify the cellular mechanisms underlying the potential of BA to stimulate invasion, we have analysed the effects of the efficient invasion stimulator LCA on the morphology of PCmsrc and HCT-8/E11 cells (Figure 8 ). In HCT-8/E11 cells grown for 20 h on glass coverslips in serum-free medium, treatment with LCA (10 mmol/l) induced cell rounding and appearance of smaller islands with more refringent borders. Furthermore, LCA inhibited filopodia formation in HCT-8/E11 cells (Figure 8 , lower panel). These effects were less clear in PCmsrc cells. On coverslips coated with collagen type I, HCT-8/E11 cells showed few filopodia, but LCA still induced cell rounding (data not shown). Under all circumstances, islands of cells were smaller and more numerous in the presence of LCA.
As shown in Figure 9 , migration of PCmsrc and HCT-8/E11 cells through Nucleopore filters was dependent upon the concentration of collagen type I used for coating the lower side of the filters. Directional cellular migration toward collagen type I was much lower in PC/AA/C1 and HCT-8/E11R1 cells than in the invasion-competent cells PCmsrc and HCT-8/E11. Furthermore, this migration towards an insoluble gradient of a substratum-bound attractant, i.e. haptotaxis, was further increased by LCA in PCmsrc and HCT-8/E11R1 cells, but not in PC/AA/ C1 and HCT-8/E11 cells. In this assay, LCA increased the number of transmigrated PCmsrc and HCT-8/E11 cells, not only to collagen type I, but also to collagen type IV and laminin. Haptotaxis of PCmsrc and HCT-8/E11 cells to fibronectin was very low and insensitive to stimulation by LCA. Transfilter migration was absent in the presence of poly-Llysine coating used as a negative control (data not shown). In time-lapse videomicrographs, random motility was not modified upon treatment with Figure 3 Effects of the glyco-and tauro-conjugated forms of the BA CDCA and LCA on invasion of PCmsrc and HCT-8/E11 cells into collagen type I. Invasion index in collagen gels as measured after 24 h at 378C, using PCmsrc and HCT-8/E11 cells incubated in the presence or absence of one of the following bile acids (10 mmol/l): CA (cholic acid), DCA (deoxycholic acid), CDCA (chenodeoxycholic acid), GCDCA and TCDCA (respectively, glyco-and tauro-chenodeoxycholic acid), LCA (lithocholic acid), GLCA and TLCA (glyco-and tauro-lithocholic acid), UDCA (ursodeoxycholic acid). Bars indicate mean values of invasion indices with upper bounds of 95% confidence intervals; statistical significance between controls and experimental data was indicated at * P50.05 or ** P50.01
LCA, as evidenced by the unchanged track lengths or membrane ruffling in HCT-8/E11 and PCmsrc cells (data not shown).
Discussion
The role of BA in normal and neoplastic growth of digestive epithelial cells is still controversial. Both beneficial and undesirable effects of BA were previously documented (Nagengast et al., 1995; Zimber et al., 2000) . Here, we show that premalignant cells exemplified by kidney epithelial MDCK cells and colon adenoma PC/AA/C1 cells are not sensitive to stimulation of invasion by BA. Our major finding is that the BA CDCA, LCA, CA, and DCA, but not UDCA, were acting as stimulators of invasion in PC/AA/C1 and MDCK cells transformed by the SRC oncogene in PCmsrc cells or the constitutively activated, small GTPase RHOA in MDCKT23-RhoAV14 cells. The MDCK cells were used to express molecules of interest, the PC/AA/C1 cells were used as a model for colorectal cancer development. These observations support the idea that genetic alterations marking the transition between the noninvasive and invasive stages do not necessarily induce invasion but make the cells competent to subsequent stimulation by local mediators, such as bile acids. Src kinase activation is considered as a frequent and early event in colon cancer progression. Furthermore, mutations at Tyr530, hampering the negative autoregulatory feedback of the Src kinase activity, are found in advanced colorectal cancers (Irby et al., 1999) . DCA induced the GTP-bound active state of both RhoA and Rac1, suggesting that these two small GTPases play a key role in the pro-invasive signaling pathways controlled by BA. Cell rounding, loss of filopodia, and enhanced haptotaxis were observed in colon cancer cells treated by BA, further indicating that these two small GTPases are an integral part of the mechanisms responsible for the acquisition of the invasive phenotype. Members of the small Rho-like GTPase family, namely RhoA, Rac1 and Cdc42, are well recognized as key regulators of the cytoskeletal organization that control epithelial integrity, cell migration and invasion . RhoA is involved in the formation of focal contacts and contractile actin-myosin filaments through interaction with several downstream effectors such as Rho kinase (ROCK). Rac1 mediates a number of adhesionand growth factor-dependent responses, including the membrane ruffling and lamellipodia formation that function in the advancement of the leading edge of migrating cells (Hall, 1998) . Accordingly, we found that MDCKT23-Rac1V12 cells expressing the constitutive activated form of Rac1 (Jou and Nelson, 1998) are invasive without the addition of stimulators (Attoub et al., 2000) . The involvement of the Rho signaling pathway in cellular invasion induced by BA was confirmed by our data using the pharmacological inhibitors of the Rho GTPases (C3T exoenzyme) and its downstream effector, ROCK (Y27632). It is, therefore, conceivable that BA stimulate tumor cell invasion through RHOA-and SRC-dependent signaling pathways.
Haptotaxis or directional migration towards an insoluble gradient of a substrate-bound attractant is implicated in the invasive phenotype (Aznavoorian et al., 1990) . Accordingly, we found a direct correlation between cell type sensitivity towards stimulation of invasion and haptotaxis in response to the different BA. Furthermore, invasion and haptotaxis were sensitive to the same pharmacological inhibitors of the signaling elements (data not shown). In contrast, there were no Figure 7 Lithocholic acid signaling and induction of cellular invasion in PCmsrc and HCT-8/E11 cells. Invasion index in collagen type I gels was measured at 378C, for PCmsrc cells (top) or HCT-8/E11 cells (bottom) incubated in the presence of lithocholic acid (LCA), either alone or combined with one of the pharmacological inhibitors of signal transduction pathways: Rho/ROCK (respectively C3 exoenzyme: 7 mg/ml and Y27632; 1 mmol/l), PI3K (Wortmannin: 10 nmol/l), PKC (GF109203X: 1 mmol/l or Go¨6976: 40 nmol/l), MAPK p42/p44 (PD98059: 20 mmol/l) and p38 (SB203580: 1 mg/ml), and cyclooxygenase COX-2 (NS-398: 10 mmol/ l). Data are mean+s.e.m. from three separate experiments. All results are statistically significant (P50.05) from the control stimulation measured in the presence of LCA changes in cell-cell and cell-matrix adhesion, and random motility upon treatment with LCA (data not shown). BA stimulate both invasion and haptotaxis in human colon cancer cells HCT-8/E11, possessing a functional E-cadherin/catenin complex, but not in its aE-catenin-deficient derivative HCT-8/E11R1 cell line (Vermeulen et al., 1999) . These results indicate that LCA-induced invasion and haptotaxis require functional E-cadherin/catenin complexes, as shown previously for the pro-invasive agents HGF, leptin and trefoil peptides . This is also supported by the neutralizing action of the E-cadherin-antibody MB2 inhibiting the cooperation between E-cadherin and integrins in wound-healing migration of intestinal cells (Andre´et al., 1999) . The putative integrin isotypes concerned in our studies are likely a1b1 and a2b1, since LCA stimulates haptotaxis to collagen types I and IV as well as to laminin, but not to fibronectin. In favor of this possibility, we found that BA-stimulated cellular invasion is inhibited by the b1 integrin neutralizing antibody.
Stimulation of tumor cell invasion by BA requires multiple signaling pathways that are strongly implicated in cancer progression, including PI3K, PKC, MAPK, and COX-2 (Hirano et al., 1996; Kurz et al., 2000; Qiao et al., 2000 Qiao et al., , 2001 . Activation of PKC by BA is well-documented in colorectal cancer cells (Huang et al., 1992; Pongracz et al., 1995; Hirano et al., 1996; Rao et al., 1997; Qiao et al., 2000) . Implication of PKC-a in stimulation of haptotaxis and invasion has also been reported in colorectal cancer HT-29 M6 and RCM-1 cells (Batlle et al., 1998; Shimao et al., 1999) . PKC activation by BA is achievable via signaling cascades involving PI3K and RhoA (Chang et al., 1998; Kurz et al., 2000; Rust et al., 2000) . In the present study, we demonstrated that LCA-stimulated invasion of PCmsrc and HCT-8/E11 cells was prevented by wortmannin, further implicating PI3-K as critical mediator of cellular invasion stimulated by oncogenes or epigenetic factors (Kotelevets et al., 1998; Attoub et al., 2000; Emami et al.,
2001
). Our results obtained with Go¨6976, an inhibitor blocking the ATP binding site within the catalytic domain of these ser/thr kinases, suggest that PKC-a and -bI are the isoenzymes likely involved in BAstimulated collagen invasion (Hofmann, 1997) . PKC inhibitors selectively interfere with positive invasion pathways (Attoub et al., 2000; Emami et al., 2001) , presumably through interruption of transcription signals controlled by the AP-1 sites (also designated as TRE, for TPA-response elements) in the regulatory region of several genetic elements implicated in cancer progression (Ozanne et al., 2000) . For example, both CDCA and DCA were shown to increase expression of the cyclooxygenase COX-2 in colorectal cancer cells, in a PKC-and MAPK-dependent manner, presumably through the action of AP-1 on a cyclic AMP responsive element (CRE) located at -56 in the COX-2 promoter (Zhang et al., 1998; Glinghammer Figure 9 Effects of various concentrations of BA on haptotaxis to collagen type I in PCmsrc and HCT-8/E11 cells. Cells were incubated with 0.1% DMSO (control) or lithocholic acid (10 mmol/ l; LCA). Abscissa: concentration of collagen type I used for substrate coating. Ordinate: mean number of cells per microscopic field as an index for cell migration with error bars for 95% confidence intervals and Rafter, 2001 ). This CRE is critical for both Rasand Rac1-induced transactivation of the COX-2 promoter. Alternatively, the COX-2 promoter might be activated through cis-acting elements located between nucleotides -80 and -40 that are required for transactivation by the RhoA and Rac1 small GTPases (Slice et al., 2000) . Downstream effectors of the invasion pathways controlled by BA are COX-2 and matrix metalloproteases (MMPs), as suggested by our data using the non-steroidal anti-inflammatory drug NS-398, and GM6001, acting on MMP1, -2, -3, -8, and -9. A recent report that forced overexpression of the COX-2 cDNA activates MMP2 is consistent with this possibility (Tsujii et al., 1997) . It has been also reported that the BA LCA activates the secretion of MMP2 in human colon cancer Caco-2 cells (Halvorsen et al., 2000) . Induction of COX-2 and accumulation of its products, such as thromboxane-A2 and prostaglandins have been implicated in the acquisition of the invasive phenotype, during the adenoma/adenocarcinoma transition and subsequent progression toward distant metastasis (Tsujii et al., 1997; Rodrigues et al., 2001) .
Most interestingly, the expression of the nuclear FXR receptor (farnesoid X receptor) for BA (Makishima et al., 1999; Parks et al., 1999; Wang et al., 1999) in invasion-competent PCmsrc and HCT-8/E11 cells led us to postulate that other transcriptional mechanisms might be implicated in the stimulation of invasion by BA. Recent data identified a BA signaling pathway leading to the activation of the FXR receptor, thereby regulating the expression of genes encoding the BA binding protein I-BABP, and CYP7a, which is involved in the major biosynthetic pathway of BA in the liver (Makishima et al., 1999; Parks et al., 1999; Wang et al., 1999) . We have also demonstrated recently that BA cooperate with retinoic acid and 1,25-dihydroxyvitamin D3 in the monocytic differentiation of human leukemic cells, through a PKC-dependent pathway, and down-regulation of the myeloblastin gene which contains a BA-responsible element (BARE-II) in its promoter (Zimber et al., 2000) . Thus, the difference in activity of the various BA in cellular invasion and haptotaxis in the present study (Figure 3 ) might be related to the expression of distinct bile acid transporters, receptors or receptor co-activators in colorectal cancer cells (Makishima et al., 1999; Parks et al., 1999; Wang et al., 1999; Staudinger et al., 2001; Xie et al., 2001) . This is in agreement with the selective implication of the LCA-specific PXR receptor in the transcriptional activation of the hepatic CYP3A4 gene, which is responsible for detoxification by hydroxylation of cholestatic BA such as LCA and other xenobiotics (Staudinger et al., 2001; Xie et al., 2001) .
In the present study, we presented some clues for elucidating the possible functional role of BA acting as invasion stimulators in SRC-and RHOA-transformed human colon and kidney epithelial cells and in colon cancer cells. In contrast, BA do not exhibit such activity in premalignant epithelial cells. Regarding to clinical relevance of our data, one can postulate that some BA, (CA, DCA, CDCA and LCA), but not UDCA, may stimulate invasion in human sporadic tumors, in addition to their known roles as mitogens, inducers or inhibitors of apoptosis in colon cancer cell lines, and in normal or adenomatous colorectal mucosa challenged with carcinogens (Kozoni et al., 2000; McMillan et al., 2000; Schlottmann et al., 2000) . In favor of this hypothesis, secondary BA are converted from primary BA by the anaerobic bacterial flora, at the site of emergence of colorectal adenomas and carcinomas. The stimulation of invasion and haptotaxis by BA, reported here, occurred at concentrations (10 -20 mmol/l) that are observed in the portal circulation (Moseley, 1999) . It is also tempting to speculate that UDCA might be useful in the treatment of colorectal cancer. Indeed, upon chronic administration, UDCA becomes the principal BA in bile, serum and stool (Kurtz, 1992; Batta et al., 1998) , presumably through a negative feedback on BA synthesis. Consistent with this observation, feeding with UDCA in a rat model of colon carcinogenesis resulted in a decreased proportion of DCA in the stool, and absence of invasive tumors (Earnest et al., 1994) .
In conclusion, our study contributes to the understanding of a role for BA in the progression of human colon tumors, through the activation of the SRC oncogene and Rho-like small GTPases, directly implicated in cellular invasion.
Materials and methods

Cell cultures
The human colon cancer HCT-8/E11 cell line and its aEcatenin-deficient round subclone HCT-8/E11R1 have been described (Vermeulen et al., 1995 (Vermeulen et al., , 1999 . Both HCT-8/E11 and HCT-8/E11R1 cell lines were maintained in RPMI-1640 medium (Life Technologies, Ghent, Belgium), supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1 mM sodium pyruvate, 100 mg/ml streptomycin, 250 IU/ml penicillin and 2.5 mg/ml fungizone. The PC/AA/C1 cell line is derived from an adenoma in a patient with familial adenomatous polyposis coli (FAP) (Williams et al., 1990) . The PCmsrc cell line was established after stable transfection of PC/AA/C1 cells by an expression vector encoding the activated (Tyr527?Phe527) form of the SRC oncogene (Empereur et al., 1997) . The PC/AA/C1 and PCmsrc cell lines were cultured in Dulbecco's Modified Eagle Medium (DMEM, Life Technologies) supplemented with 20% FBS, 8 mM L-glutamine, 100 mg/ml streptomycin, 250 IU/ml penicillin, 2.5 mg/ml fungizone, 1.75 mmol/l insulin and 1 mg/ml hydrocortisone. The dog epithelial kidney MDCKT23 cell line and its derivatives transfected with mutant cDNAs encoding the dominant-constitutive and -negative forms of the gene encoding for the RhoA GTPase (RHOA) under the control of a tetracycline-repressible transactivator (MDCKT23-RhoAV14 and MDCKT23-RhoAN19 cells) were obtained from Dr WJ Nelson (Department of Molecular and Cellular Physiology, Stanford, CA, USA). These MDCK cell lines were cultured in DMEM medium supplemented with: 10% FBS, 100 IU/ml streptomycin, 250 IU/ml penicillin, 2.5 mg/ml fungizone, 200 mg/ml hygromycin (Roche Diagnostics, GmbH, Mannheim, Germany), and 20 ng/ml doxycycline (Sigma, St Louis, MO, USA) (Jou and Nelson, 1998) . Before the invasion assay, MDCKT23 cell lines were cultured in the continuous presence of doxycycline (for continuous repression of the ectopic expression of the Rho mutants by the tetracycline repressible transactivator), or in its absence for 48 h (for induction of the RHOA mutants). All cell lines used were mycoplasma-free, as tested by DAPI-staining (Sigma).
Reagents and antibodies
BA, lysophosphatidic acid, poly-L-lysine, human fibronectin, and collagen type IV were from Sigma. Clostridium botulinum exoenzyme C3 transferase (C3 exoenzyme) that ADPribosylates and inactivates the small GTPase Rho proteins was previously described (Rodrigues et al., 2001) . The Rho kinase inhibitor Y27632 was kindly provided by Yoshitomi Pharmaceutical Industries Ltd (Osaka, Japan). The pharmacological inhibitors of the PKC isoforms -a and -bI (Go6 976), and -a, -bI, -bII, -g, and -e isoforms (GF109203X), PI-3 kinase (wortmannin), COX-2 (NS-398) were from Calbiochem (La Jolla, CA, USA). The mitogen-activated protein kinase (MAPK) inhibitors 2'-amino-3'methoxyflavone (PD98059, specific for p42/p44) and SB203580 (specific for p38 MAPK) were from Alexis Corporation (San Diego, CA, USA) and New England Biolabs, Inc. (Beverly, MA, USA) respectively. Laminin was from Roche Diagnostics GmBH. PD98059, SB203580 and BA were first dissolved in DMSO and further diluted in culture medium. Final concentrations of DMSO did not exceed 0.1%. BA were used at 10 mmol/l,, unless otherwise indicated. The matrix metalloprotease inhibitor MMP GM6001 (Galardyn) was from Chemicon International (Temecula, CA, USA). Mouse IgG1 monoclonal antibody (mAb P4C10) against the b1 integrin subunit was from Life Technologies. Rat IgG2a mAb 69.6.5 against aV integrin subunit was a gift from J-C Lissitzky (Lehmann et al., 1994) . Mouse IgG2b mAb MB2, a functionallyneutralizing E-cadherin antibody was used, as described previously (Bracke et al., 1993) .
Collagen invasion assay
Collagen type I gels (from rat tail, Upstate Biotechnology, Lake Placid, NY, USA) were prepared in DMEM (0.22% w/v), using 6-well plates, as described (Vakaet et al., 1991) . Cells were seeded on top of the collagen gels, with or without drugs or antibodies. After 24 h incubation at 378C, the invasion index was calculated from the mean number of invasive cells, over the total number of cells, counted in at least 12 microscopic fields. Cell viability was evaluated by the trypan blue exclusion test (Sigma).
Morphotype on solid substrate
For seeding on solid substrate, cells were detached with trypsin/EDTA (Life Technologies) from a nearly confluent monolayer, washed in PBS, suspended in FBS-free medium and seeded on glass coverslips that were coated at 378C for 2 h with 10 mg/ml collagen type I in PBS. Cultures were incubated for 20 h.
Assays for motility
For time-lapse videomicroscopy, we used freshly seeded or confluent cell cultures in 6-well plates. Time-lapse images were recorded with an inverted microscope (phase-contrast; objective 206 to evaluate random motility and 406 to evaluate membrane ruffling). The inverted microscope was connected with an MTI CCD72 camera (Dage MTI, Michigan City, IN, USA) and a U-matic VO-5850P videorecorder (Sony, Tokyo, Japan) at 30 s intervals. Track lengths were measured as described (Bracke et al., 1997) . Haptotaxis assays (Aznavoorian et al., 1990) were performed in 48-well microchemotaxis chambers (NeuroProbe Inc., Bethesda, MD, USA) with 8-mm pore size Nucleopore filters (Costar, Cambridge, MA, USA). The lower surface of each filter was precoated for 1 -2 h at 378C with purified matrix proteins, at the indicated concentrations. The lower compartment was filled with 33 ml medium containing BA, drugs or antibodies. Cells (12 500 for HCT-8/E11 and HCT-8/E11R1 cells; 50 000 for PC/AA/C1 and PCmsrc cells) were dissolved in 50 ml medium containing BA, drugs or antibodies, added to the upper compartment, and incubated for 4 -6 h. Membranes were then fixed in methanol and stained with 10% Giemsa. Non-migratory cells on the upper surface of the filter were wiped with a cotton swab and cell number on the lower surface of the filter was quantified by counting 10 fields per well (objective: 640, ocular: 610). All experiments were performed at least in triplicate.
Western blotting
Cells were lysed in the Laemmli buffer. Proteins (50 mg) were separated by 7.5% or 12% SDS -PAGE under reducing conditions and transferred onto Hybond nitrocellulose or PVDF membranes (Amersham Pharmacia Biotech, Buckinghamshire, UK). After blockage with 5% non-fat dry milk in PBS with 0.5% Tween-20, membranes were incubated with mAbs directed against Rac1 (Upstate Biotechnology, Lake Placid, NY, USA) or RhoA (Santa Cruz Biotechnology), or with antibodies against the mouse, rat and human FXR receptor (1 : 200; sc-1204; Santa Cruz Biotechnology, Santa Cruz, CA, USA), followed by washing, and incubation with anti-mouse (Santa Cruz Biotechnology) or anti-goat antibodies (Santa Cruz Biotechnology) conjugated with horseradish peroxidase. The ECL staining reagent was from Amersham Pharmacia Biotech.
Determination of Rac1 and RhoA activation by pull-down assays
The levels of the active small GTPases Rac1 and RhoA under GTP-bound forms were measured as described (Sander et al., 1998; Zondag et al., 2000) . GTP-bound Rac1 or GTP-bound RhoA GTPases were respectively precipitated by PAK (p21-activated kinase-1) or the C21 fragment of rhotekin, each fused to glutathione-S transferase precoupled to glutathioneSepharose beads. The total amount of these two GTPases in cell lysates, and their corresponding GTP-bound fractions were detected by Western blot analysis. Immunoblots were quantitated with the Quantity One Software (Bio-Rad Laboratories, Hercules, CA, USA).
Statistical analysis
Data on collagen type I invasion and haptotaxis were analysed by the Student t-test and the non-parametric Mann -Whitney U test, with P50.05 considered as statistically significant.
